These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15158967)

  • 41. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks.
    de Matas M; Shao Q; Richardson CH; Chrystyn H
    Eur J Pharm Sci; 2008 Jan; 33(1):80-90. PubMed ID: 18035525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin-micro- and nanoparticles for pulmonary delivery.
    Klingler C; Müller BW; Steckel H
    Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aerosol delivery devices in the treatment of asthma.
    Hess DR
    Respir Care; 2008 Jun; 53(6):699-723; discussion 723-5. PubMed ID: 18501026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Teaching the inhalation manoeuvre to asthmatic children by means of visual feedback].
    Kamin W; Kreplin A
    Pneumologie; 2007 Mar; 61(3):150-6. PubMed ID: 17342574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adherence logger for a dry powder inhaler: a new device for medical adherence research.
    Bogen D; Apter AJ
    J Allergy Clin Immunol; 2004 Oct; 114(4):863-8. PubMed ID: 15480328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aerosol therapy: the special needs of young children.
    Janssens HM; Tiddens HA
    Paediatr Respir Rev; 2006; 7 Suppl 1():S83-5. PubMed ID: 16798606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Understanding medication and use of drug delivery device by asthmatic in Lagos.
    Adeyeye OO; Onadeko BO
    West Afr J Med; 2008 Jul; 27(3):155-9. PubMed ID: 19256320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD.
    Onoue S; Yamada S; Yajima T
    Peptides; 2007 Sep; 28(9):1640-50. PubMed ID: 17537541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers.
    Khassawneh BY; Al-Ali MK; Alzoubi KH; Batarseh MZ; Al-Safi SA; Sharara AM; Alnasr HM
    Respir Care; 2008 Mar; 53(3):324-8. PubMed ID: 18291048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study.
    Van Dyke RE; Nikander K
    Respir Care; 2007 Feb; 52(2):184-90. PubMed ID: 17261207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Part II: Inhaler technique and adherence to therapy.
    Blaiss MS
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S13-20. PubMed ID: 17925064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of five patient-controlled analgesia drug delivery devices].
    Inoue S; Mitsuhata H; Hirabayashi Y; Kawakami T; Tsukamoto N; Konishi R; Soutome K; Akazawa S; Shimizu R
    Masui; 1999 Jun; 48(6):682-6. PubMed ID: 10402830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhalation devices--which is best for your patient?
    Yule H
    Hosp Pharm; 1992 Nov; 27(11):1010-2, 1015. PubMed ID: 10122038
    [No Abstract]   [Full Text] [Related]  

  • 56. Selecting inhaler devices for children with asthma.
    Roberts J
    Prof Care Mother Child; 1997; 7(2):43-6. PubMed ID: 9220830
    [No Abstract]   [Full Text] [Related]  

  • 57. Pulmonary drug delivery system: newer patents.
    Kaur SS
    Pharm Pat Anal; 2017 Sep; 6(5):225-244. PubMed ID: 28818001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of the moisture on the performance of a new dry powder inhaler.
    Maggi L; Bruni R; Conte U
    Int J Pharm; 1999 Jan; 177(1):83-91. PubMed ID: 10205605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AARC (American Association of Respiratory Care) clinical practice guideline. Selection of an aerosal delivery device for neonatal and pediatric patients.
    Respir Care; 1995 Dec; 40(12):1325-35. PubMed ID: 10153259
    [No Abstract]   [Full Text] [Related]  

  • 60. Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments.
    Walsh J; Bickmann D; Breitkreutz J; Chariot-Goulet M;
    Int J Pharm; 2011 Aug; 415(1-2):221-31. PubMed ID: 21640807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.